Loading
MB
Monogram Biosciences, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by SIEBEL KENNETH F, was filed 02 Jan 2009.
Monogram Biosciences, Inc.: what insiders have been doing
Monogram Biosciences, Inc. is a listed company. Its insiders report their share dealings to SEC (Form 4). No insider at Monogram Biosciences, Inc. has published a filing in the past twelve months. The most recent one dates from 6 October 2009.
Our records for Monogram Biosciences, Inc. go back to 2007, with 50 purchases and 12 sales on the open market in total.
Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Insider Decl.
68
Thresholds
n/a
Buy Volume
€3M
50 ops. · all time
Sell Volume
€708,190
12 ops. · all time
Financial data
· cache
Last declaration on 6 October 2009
Declarations68 total
1,635,333 shares@ US$4.55Common StockSEC:0001144204-09-051816:0
1,425,138 shares@ US$4.55Common StockSEC:0001144204-09-051816:1
10,623,670 shares@ US$4.55Common StockSEC:0000920148-09-000057:0
16,666 shares@ US$3.50Common StockSEC:0001144204-09-029373:0
3,334 shares@ US$2.99Common StockSEC:0001144204-09-011340:0
1,200 shares@ US$4.24Common StockSEC:0001144204-09-011340:1
5,466 shares@ US$3.53Common StockSEC:0001144204-09-011340:2
1,666 shares@ US$2.20Common StockSEC:0001144204-09-000672:0
25,000 shares@ US$2.20Common StockSEC:0001144204-09-000094:0
Canonical exit: 30 Mar 2009 (T+90)
22,000 shares@ US$2.21Common StockSEC:0001144204-09-000094:1
Canonical exit: 31 Mar 2009 (T+90)
10,000 shares@ US$2.21Common StockSEC:0001144204-09-000094:2
Canonical exit: 31 Mar 2009 (T+90)
20,000 shares@ US$2.22Common StockSEC:0001144204-08-071620:0
Canonical exit: 26 Mar 2009 (T+90)
50,000 shares@ US$2.15Common StockSEC:0001144204-08-071620:1
Canonical exit: 29 Mar 2009 (T+90)
189,325 shares@ US$2.17Common StockSEC:0001144204-08-071620:2
189,325 shares@ US$2.17Common StockSEC:0001144204-08-071620:3
Canonical exit: 26 Mar 2009 (T+90)
15,000 shares@ US$2.14Common StockSEC:0001144204-08-071620:4
Canonical exit: 29 Mar 2009 (T+90)
8,333 shares@ US$2.00Common StockSEC:0001144204-08-069869:0
15,000 shares@ US$1.80Common StockSEC:0001144204-08-068982:0
Canonical exit: 11 Mar 2009 (T+90)
20,000 shares@ US$1.53Common StockSEC:0001144204-08-068889:0
Canonical exit: 10 Mar 2009 (T+90)
15,000 shares@ US$1.66Common StockSEC:0001144204-08-068468:0
Canonical exit: 8 Mar 2009 (T+90)
6,000 shares@ US$2.06Common StockSEC:0001144204-08-068465:0
Canonical exit: 26 Feb 2009 (T+90)
144,325 shares@ US$2.15Common StockSEC:0001144204-08-068463:0
Canonical exit: 22 Feb 2009 (T+90)
144,325 shares@ US$2.15Common StockSEC:0001144204-08-066899:1
144,325 shares@ US$2.15Common StockSEC:0001144204-08-066899:0
Canonical exit: 22 Feb 2009 (T+90)
2,787 shares@ US$2.00Common StockSEC:0001144204-08-066436:0
Canonical exit: 18 Feb 2009 (T+90)
25 of 68 declarations
About Monogram Biosciences, Inc.
Monogram Biosciences, Inc. is a company focused on developing diagnostic tests for personalized medicine. It aims to enhance treatments for patients with cancer and other serious diseases.
